| Opposing functions of Akt isoforms in lung tumor initiation and progression NM Linnerth-Petrik, LA Santry, JJ Petrik, SK Wootton PloS one 9 (4), e94595, 2014 | 82 | 2014 |
| Combining vascular normalization with an oncolytic virus enhances immunotherapy in a preclinical model of advanced-stage ovarian cancer K Matuszewska, LA Santry, JP van Vloten, AWK AuYeung, PP Major, ... Clinical Cancer Research 25 (5), 1624-1638, 2019 | 73 | 2019 |
| Use of precision-cut lung slices as an ex vivo tool for evaluating viruses and viral vectors for gene and oncolytic therapy MCR Gerpe, JP van Vloten, LA Santry, J de Jong, RC Mould, A Pelin, ... Molecular therapy Methods & clinical development 10, 245-256, 2018 | 56 | 2018 |
| Akt isoform specific effects in ovarian cancer progression NM Linnerth-Petrik, LA Santry, R Moorehead, M Juecker, SK Wootton, ... Oncotarget 7 (46), 74820, 2016 | 53 | 2016 |
| Production and purification of high-titer Newcastle disease virus for use in preclinical mouse models of cancer LA Santry, TM McAusland, L Susta, GA Wood, PP Major, JJ Petrik, ... Molecular Therapy Methods & Clinical Development 9, 181-191, 2018 | 50 | 2018 |
| AAV vector distribution in the mouse respiratory tract following four different methods of administration LA Santry, JC Ingrao, DL Yu, JG de Jong, LP van Lieshout, GA Wood, ... BMC biotechnology 17, 1-11, 2017 | 49 | 2017 |
| Genetic characterization of small ruminant lentiviruses circulating in naturally infected sheep and goats in Ontario, Canada LA Santry, J de Jong, AC Gold, SR Walsh, PI Menzies, SK Wootton Virus research 175 (1), 30-44, 2013 | 40 | 2013 |
| Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice NM Linnerth-Petrik, LA Santry, DL Yu, SK Wootton PLoS One 7 (12), e51400, 2012 | 30 | 2012 |
| Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models TM McAusland, JP van Vloten, LA Santry, MM Guilleman, AD Rghei, ... Molecular Therapy-Oncolytics 20, 306-324, 2021 | 28 | 2021 |
| Quantifying antigen-specific T cell responses when using antigen-agnostic immunotherapies JP van Vloten, LA Santry, TM McAusland, K Karimi, G McFadden, ... Molecular Therapy-Methods & Clinical Development 13, 154-166, 2019 | 24 | 2019 |
| Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease BM Warner, LA Santry, A Leacy, M Chan, PH Pham, R Vendramelli, Y Pei, ... IScience 24 (11), 2021 | 22 | 2021 |
| Tumour vasculature: Friend or foe of oncolytic viruses? LA Santry, JP van Vloten, JP Knapp, K Matuszewska, TM McAusland, ... Cytokine & Growth Factor Reviews 56, 69-82, 2020 | 22 | 2020 |
| Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer JP Van Vloten, K Matuszewska, MAA Minow, JA Minott, LA Santry, ... Journal for Immunotherapy of Cancer 10 (3), 2022 | 19 | 2022 |
| Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse … K Matuszewska, S Ten Kortenaar, M Pereira, LA Santry, D Petrik, KM Lo, ... Gynecologic Oncology 164 (1), 154-169, 2022 | 18 | 2022 |
| Aav vectored immunoprophylaxis for filovirus infections AD Rghei, LP van Lieshout, LA Santry, MM Guilleman, SP Thomas, ... Tropical Medicine and Infectious Disease 5 (4), 169, 2020 | 15 | 2020 |
| AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challenge MM Guilleman, BAY Stevens, LP Van Lieshout, AD Rghei, Y Pei, ... Gene Therapy 30 (5), 455-462, 2023 | 11 | 2023 |
| Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy JP Van Vloten, JA Minott, TM McAusland, JC Ingrao, LA Santry, ... Molecular Therapy-Methods & Clinical Development 23, 434-447, 2021 | 10 | 2021 |
| Interference chromatography: A novel approach to optimizing chromatographic selectivity and separation performance for virus purification LA Santry, R Jacquemart, M Vandersluis, M Zhao, JM Domm, ... BMC biotechnology 20, 1-15, 2020 | 10 | 2020 |
| Truncation of the enzootic nasal tumor virus envelope protein cytoplasmic tail increases Env-mediated fusion and infectivity SR Walsh, JG de Jong, JP van Vloten, MCR Gerpe, LA Santry, ... Journal of General Virology 98 (1), 108-120, 2017 | 8 | 2017 |
| Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis AD Rghei, JGE Yates, JA Lopes, X Zhan, MM Guilleman, Y Pei, ... Gene Therapy, 1-12, 2023 | 4 | 2023 |
